Showing 1051-1060 of 2049 results for "".
- 2025 AAD: What’s New and True for Energy-Based Deviceshttps://modernaesthetics.com/news/2025-aad-whats-new-and-true-for-energy-based-devices/2473763/At the 2025 American Academy of Dermatology (AAD) Annual Meeting, Modern Aesthetics sat in on “What’s New and What’s True for Energy-Based Devices (EBDs).” The speakers of this lecture included Suzanne L Kilmer, MD, FAAD; Arielle N.B. Kauvar, MD, FAAD; Merete Haedersdal, MD, PhD, FAAD; Jill S. Wa
- Sculptra Scores FDA Nod for Cheek Wrinkleshttps://modernaesthetics.com/news/sculptra-scores-fda-nod-for-cheeks/2473402/The U.S. Food and Drug Administration (FDA) has approved Sculptra (injectable poly-L-lactic acid (PLLA-SCA)) for the correction of fine lines and wrinkles in the cheek area. Sculptra is the first FDA-approved PLLA collagen stimulator that helps stimulate natural collagen produ
- Dermatologists React to Threat of Coronavirus Pandemichttps://modernaesthetics.com/news/dermatologists-react-to-threat-of-coronavirus-pandemic-1/2472891/Reports about COVID-19 are causing many dermatologists and aesthetic physicians to rethink their travel plans and update their office policy on the care of sick patients. The International Health Regulations Emergency Committee of the World Health Organization declared the outbreak a &l
- Imaging Study Explores Tissue Repair Dynamics After UltraClear Laser Therapyhttps://modernaesthetics.com/news/imaging-study-explores-tissue-repair-dynamics-after-ultraclear-laser-therapy/2487167/Serial line-field confocal optical coherence tomography (LC-OCT) imaging may provide a noninvasive method for visualizing tissue repair following laser-coring procedures, according to findings published in Lasers in Surgery and Medicine.1 In the technical demonstration
- SCALE 2026: Ipsen Reports Phase 2 Corabotase Data in Glabellar Lineshttps://modernaesthetics.com/news/scale-2026-ipsen-reports-phase-2-corabotase-data-in-glabellar-lines/2487141/Ipsen presented late-breaking Phase 2 data for corabotase, its investigational recombinant neuroinhibitor, in moderate-to-severe glabellar lines at the 2026 SCALE Symposium in Nashville, Tennessee. The study included 183 patients. At week 4, 66% of patients treated with corabotase 50 ng ac
- Direct Brow Lift Shows Durable Results and High Satisfaction in Prospective Studyhttps://modernaesthetics.com/news/direct-brow-lift-shows-durable-results-and-high-satisfaction-in-prospective-study/2487140/A prospective study published online ahead of print in Aesthetic Plastic Surgery evaluated the long-term efficacy, scar-related outcomes, and patient satisfaction associated with the direct brow lift using the Castanares tec
- LaserAway Marks 20 Years with Continued National Expansionhttps://modernaesthetics.com/news/laseraway-marks-20-years-with-continued-national-expansion/2487069/LaserAway is celebrating its 20th anniversary alongside continued national expansion and recent recognition within the aesthetics industry. The company, which specializes in aesthetic dermatology services, announced that it now operates more than 215 clinics across the United States. The c
- ASLMS 2026: Lumenis Reports New Laser Findings in Scalp Treatment, Rhinophyma, Photodamaged Skinhttps://modernaesthetics.com/news/aslms-2026-lumenis-reports-new-laser-findings-in-scalp-treatment-rhinophyma-photodamaged-skin/2487036/Lumenis Be Ltd. presented new clinical data on several aesthetic devices at the 45th Annual American Society for Laser Medicine and Surgery Conference, held May 7-9, 2026, in Savannah, Georgia, according to a company announcement. The presentations included data on FoLix, a 1565-nm nonabla
- Rapalogix Health Launches Re-Q Pro-Longevity Serum with Focus on Cellular Skin Aginghttps://modernaesthetics.com/news/rapalogix-health-launches-re-q-pro-longevity-serum-with-focus-on-cellular-skin-aging/2487003/Rapalogix Health has introduced its new Re-Q Pro-Longevity Face Serum during a virtual launch event on Thursday, May 7, featuring co-Founder and board-certified dermatologist Doris Day, MD, and co-Founder and CEO Rahul Mehta. The webinar focused on the science behind the product and the company’s
- Review Examines Dermatologic Effects of Rapid Weight Losshttps://modernaesthetics.com/news/review-examines-dermatologic-effects-of-rapid-weight-loss/2486984/Rapid weight loss associated with bariatric surgery, glucagon-like peptide-1 receptor agonists (GLP-1 RA), and intensive lifestyle interventions may contribute to dermatologic and structural changes that extend beyond reduced body size, according to a narrative rev